-
FEATURE: The cancer breakthroughs most never get to hear about
26 October 2023
An all-star cast of integrative cancer clinicians came together for the Beljanski Integrative Cancer Conference in Jacksonville, Florida, to share their life saving knowledge and findings, while ANH-USA receives award
-
ANH News Beat (week 8/2023)
23 February 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 27/2023)
06 July 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Rob Verkerk PhD with Charles Kovess on the Mind Medicine Show, TNT Radio
06 September 2023
Dive into the wide ranging, natural health-related discussion between Rob Verkerk PhD and Charles Kovess on the TNT Radio Mind Medicine Show last weekend
-
Are you up for taking Big Pharma's new 'skinny' jab?
16 March 2023
After a succession of Big Pharma failures for anti-obesity drugs, will Novo Nordisk's latest offering, that emerges from something of a dark cloud, be just another side effect ladened sticking plaster, or a boon for users and a cash cow for its manufacturer?
-
ANH News Beat (week 5/2023)
01 February 2023
A roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Rob Verkerk PhD on TNT Mind Medicine show
15 February 2023
ANH founder, Rob Verkerk PhD, got up extra early to join Charles Kovess on the Mind Medicine show on TNT Radio recently
-
Current vaccine state of play and the new kid on the block: Valneva
21 April 2022
Latest insights from ANH founder, Rob Verkerk PhD
News / ANH Covid Zone / Health / Campaigns
-
Natural News Roundup & Covid Corner (week 16/2022)
21 April 2022
'Good' cholesterol protects against Alzheimer's; E-cigarettes not as healthy as touted; Verizon told shut down cellphone tower; Covid Corner
-
Pathfinder members' Q&A session April 2022
19 April 2022
Zoom recording of our Pathfinder members' Q&A for April 2022